Custom Search

Brand Name(s): Coreg; Dilatrend; Eucardic
CAS nº: 72956-09-3
(car VAY dih lol)

About carvediol

This new site is dedicated exclusively to carvediol (carvedilol).

It offers you the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about carvediol (carvedilol), as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site also provides you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total carvediol experience! 

Why is this medication prescribed?

Carvediol (carvedilol) is an alpha and beta-blocker used to treat high blood pressure and heart failure. It is also used after an acute heart attack to improve survival. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.

This drug works by blocking the action of certain natural chemicals in the body (such as epinephrine) that affect the heart and blood vessels. This results in a lowering of heart rate, blood pressure, and strain on the heart.

It is marketed under various brand names, including Coreg® (GSK), Dilatrend® (Roche) and Eucardic® (Roche).

 

See more Product Info

Latest News

New Beta Blocker Drug Reduces Heart Risks

Carvedilol, a newer member of the beta blocker family of heart drugs, saved more lives of patients...

[more]

FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions

GlaxoSmithKline (NYSE: GSK - News) and Flamel Technologies (Nasdaq: FLML - News) today announced...

[more]

Flamel’s losses soar as it gears up for Coreg

As it prepares for the launch of GlaxoSmithKline’s beta-blocker Coreg (carvedilol) with a...

[more]

New Data Show COREG CR (TM) Reduced Blood Pressure In Patients With Essential Hypertension

Philadelphia - Coreg CR(TM) (carvedilol phosphate controlled-release capsules), a...

[more]

Taro Receives Tentative ANDA Approvals For Carvedilol Tablets

Hawthorne, N.Y.(PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. and its affiliates and...

[more]

Use of this site is subject to the following terms of use